Study: Cheap chemo drug greatly boosts survival for men with advanced prostate cancer

June 1, 2014 10:40 PM

17 0

CHICAGO -- A cheap, decades-old chemotherapy drug extended life by more than a year when added to standard hormone therapy for men whose prostate cancer has widely spread, doctors reported Sunday.

Men who received docetaxel, sold as Taxotere and in generic form, lived nearly 58 months versus 44 months for those not given the drug, a major study found.

Read more

To category page